SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039054
Filing Date
2023-08-07
Accepted
2023-08-07 16:06:48
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20230630.htm   iXBRL 10-Q 2904622
2 EX-10.1 annx-ex10_1.htm EX-10.1 43252
3 EX-10.2 annx-ex10_2.htm EX-10.2 155623
4 EX-31.1 annx-ex31_1.htm EX-31.1 21247
5 EX-31.2 annx-ex31_2.htm EX-31.2 20733
6 EX-32.1 annx-ex32_1.htm EX-32.1 19902
  Complete submission text file 0000950170-23-039054.txt   8363027

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT annx-20230630.xsd EX-101.SCH 38951
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT annx-20230630_def.xml EX-101.DEF 139238
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT annx-20230630_lab.xml EX-101.LAB 362680
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT annx-20230630_cal.xml EX-101.CAL 43533
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT annx-20230630_pre.xml EX-101.PRE 261798
52 EXTRACTED XBRL INSTANCE DOCUMENT annx-20230630_htm.xml XML 1385691
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 231147631
SIC: 2834 Pharmaceutical Preparations